These iPSC-based models promise to clarify how neurons with SLC13A5 variants respond to changes in citrate levels while elucidating the molecular and cellular mechanisms underpinning epilepsy and drug resistance in individual patients. The gene discussed is SLC13A5; the disease is epilepsy.